Th2A and Th17 cell frequencies and regulatory markers as follow-up biomarker candidates for successful multifood oral immunotherapy

Allergy. 2020 Jun;75(6):1513-1516. doi: 10.1111/all.14180. Epub 2020 Jan 31.

Authors

Sonia Luce¹, Sharon Chinthrajah^{2

3}, Shu-Chen Lyu^{2

3}, Kari C Nadeau^{2

3}, Laurent Mascarell¹

Affiliations

¹ Research Department, Stallergenes Greer, Antony, France.
² Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Stanford, CA, USA.
³ Division of Pulmonary and Critical Care Medicine and Division of Allergy, Immunology and Rheumatology, Stanford University, Stanford, CA, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Biomarkers
Follow-Up Studies
Immunotherapy*
T-Lymphocytes, Regulatory
Th17 Cells*

Substances

Biomarkers

Grants and funding